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Toll-like receptors (TLRs) and NK cell receptors are the most important receptor superfamilies in innate immunity. TLRs act as 
the sensor of external pathogens, while NK cells detect alterations in endogenous protein expression on target cells through acti-
vating and inhibitory receptors. Accumulating data has demonstrated that TLRs and NK cell receptors can coordinate and regulate 
each other during immune responses, which contributes to the initiation of innate response and the priming of adaptive responses. 
TLRs can activate NK cell function directly or with the help of accessory cells in a cytokine or cell-to-cell contact dependent 
manner. More understanding of the recognition of innate receptors and interactions between them may provide important insights 
into the design of effective strategies to combat tumor and microbial infections. In this review, we summarize how TLRs and NK 
cells discriminate the self or non-self components respectively. And importantly, we pay more attention to the role of TLR sig-
naling in induction of NK cell activation, responses and the crosstalk between them. 
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The innate immune system in mammalian has evolved a 
universal and conservative defense line against the invasion 
from exotic micro-organisms and autogenous transformed 
objects. The early concept about innate immunity believed 
that it can nonspecifically eliminate microbes because in-
nate immune cells exert their function without pre-sensi-     
tization; however, the discovery of Toll-like receptors (TLRs) 
in the mid-1990s showes that pathogen recognization by the 
innate immune system actually relies on germline-encoded 
pattern-receptors (PRRs) that have evolved to detect com-
ponents of foreign pathogens, also known as pathogen-  
associated molecular patterns (PAMPs) [1–3]. So far four 
classes of PRRs have been identified: TLRs, RIG-I-like 
receptors (RLRs), NOD-like receptors (NLRs) and C-type 
lectin receptors (CLRs) [4]. Among them, TLRs have the 
most greatly advanced understanding of how they recognize 
conserved structures in pathogens and trigger innate im-
mune response to further prime antigen-specific adaptive 
immunity. 
Natural killer (NK) cells are innate effector cells that 
play a critical role in immunosurveillance by eliminating 
virally infected and transformed cells via generating and 
secreting cytolytic granules or cytokines, as well as ex-
pressing several activating and inhibitory receptors on the 
surface [5]. Equally as the essential components of the in-
nate immune system, NK cells and TLRs bear unique 
mechanism to sense dangerous signals and exert immune 
effect. On the other hand, they coordinate with each other to 
control the invasion of acataleptic challenges [6,7]. In this 
review, we survey how TLRs and NK cells discriminate the 
self and non-self components respectively. And importantly, 
we pay more attention to the present knowledge of how 
TLRs affect the function of NK cells and the crosstalk be-
tween them. 
1  TLRs—The sensors of external stimulator 
TLRs, acting as the sensors of external pathogens, are one 
of the most important PRRs. They are expressed on almost 
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all immune cells, such as DCs, monocytes, macrophages, T 
cell, B cell, NK cells, and even on non-immune cells such 
as fibroblasts, epithelial cells and some tumor cells [8]. 
Although TLRs are evolutionarily conserved from the worm 
Caenorhabditis elegans to mammals, the expression of 
TLRs is not stable but constantly variable in response to 
environmental stress such as virus or bacteria infection [9]. 
TLRs generally detect microbes-related components which 
are usually called PAMPs to activate transcriptional pro-
grams that initiate innate immune responses and orchestrate 
acquired antigen-specific resistance to exogenetic insults 
[10]. Stimulation of TLRs by these microbial products, such 
as lipids, lipoproteins, lipopolysaccharide (LPS) and nucleic 
acids, leads to the activation of signaling pathways that re-
sult in the up-regulation of antimicrobial genes and the se-
cretion of some inflammatory cytokines or IFNs to start up 
the defense responses [11,12].  
So far, over ten kinds of functional TLRs have been elu-
cidated in mammals, including 10 in humans and 12 in mice 
respectively, with TLR1-TLR9 being conserved in both 
species [13]. These TLRs are roughly divided into two sub-
families depending on their cellular localization and respec-
tive PAMP ligands. One group is composed of TLR1, TLR2, 
TLR4, TLR5, TLR6 and TLR11, which are expressed on 
cell surface and recognize mainly microbial lipids compo-
nents such as LPS and lipoproteins; the other group mainly 
includes TLR3, TLR7, TLR8 and TLR9, which are ex-
pressed exclusively in intracellular vesicles such as endo-
plasmic reticulum (ER), endosomes, lysosomes and endo-
lysosomes, where they recognize microbial nucleic acids 
components such as double-stranded RNA (dsRNA), sin-
gle-stranded RNA (ssRNA), unmethylated-CpG DNA mo-
tifs respectively [14,15]. So it is essential for these “nucleic 
acid-sensing” TLRs to internalize to the endosome before 
signaling is possible. Study of mice deficient with each TLR 
has demonstrated that each TLR has a distinct deflection in 
terms of PAMP recognition to perform their duty to coun-
teract the extraneous invasion.  
For example, TLR4 stimulation with LPS is the main 
force to resist the Gram-negative bacterial infection. For 
recognition, TLR4 needs the presence of complex from 
CD14 and MD-2 in the assist of LPS-binding protein (LBP) 
[16]. For infection of Gram-positive bacteria, TLR2, rather 
than TLR4, plays a major role to clear away the pathogenic 
bacteria due to the deficiency of LPS. TLR2 forms hetero-
dimers with TLR1 or TLR6 to recognize its ligands, the 
microbial components from Gram-positive bacterial, fungi, 
parasites and virus, including LTA, lipoproteins, and PG 
[17,18]. Moreover, some co-receptors on the cell surface 
can assist PAMP recognition of TLR2. These include CD36, 
which acts together with the TLR2-TLR6 heterodimer to 
mediate the sensing of some TLR2 agonists [19]; and dectin-1, 
a C-type lectin that binds to fungus -glucan and induces its 
internalization [20]. In addition to recognizing compounds 
derived from Gram-positive bacteria, TLR2 also binds LPS 
in the presence of LBP and CD14 and induces nuclear factor 
(NF)-κB activation. LPS treatment has been demonstrated 
to enhance the oligomerization of TLR2. Concomitant with 
receptor oligomerization, the IL-1R-associated kinase is 
recruited to the TLR2 complex [21]. Viral structural com-
ponents, including viral DNA, dsRNA, ssRNA, can activate 
“nucleic acid-sensing TLRs”, including TLR3, TLR7, TLR8 
and TLR9 to eliminate the viral-invasion cells via inducing 
type I IFN and antiviral factors production [22]. 
Structurally, TLRs are type I trans-membrane proteins 
characterized by the extracellular domains containing leu-
cine-rich repeats that mediate the recognition of PAMPs, 
transmembrane domains, and the intracellular Toll-inter-     
leukin 1 (IL-1) receptor (TIR) domains [23]. After binding 
with corresponding ligands, TLRs dimerize and undergo 
conformational changes required for the recruitment of TIR- 
domain-containing adaptor molecules to the TIR domain of 
the TLRs. Although with structural similarity, accumulating 
evidence suggests that the signaling pathways associated 
with each TLR are not identical, and therefore, result in 
different biological responses. For example, activation of 
TLR3 and TLR4 signaling pathway generates both type I 
IFN and inflammatory cytokine responses whereas TLR1/ 
TLR2, TLR2/TLR6 and TLR5 activation induces mainly 
inflammatory cytokines such as IL-6, TNF-α and IL-8 [24].  
2  Recognition of NK cell receptors: Discrimi-
nation of “self” and “non-self” 
NK cells participate in immunosurveillance by directly 
eliminating virally infected or transformed cells through 
killing target cells, and priming adaptive lymphocytes through 
secretion of cytokines, such as IL-12 and IFN- [25]. NK 
cells, identical to other lymphocytes, have the potential to 
attack autologous cells. However, there are unique mecha-
nisms to ensure that NK cells can keep the “self-tolerance” 
to normal self cells but are standby to danger signals. The 
NK cell function relies upon signals from activation and 
inhibitory receptors whose ligands are largely endogenous, 
that is, encoded by host genes. During effector responses, 
NK cells may detect alterations in endogenous protein ex-
pression on target cells by integrating signals from the bal-
ance between inhibitory and activating receptors [26,27]. 
2.1  Missing-self recognition by NK cells or NK cell self- 
tolerance 
NK cells are lymphocytes that derived from bone-marrow 
precursors. During the development of NK cells, NK-cell 
precursors (NKp) generated from multipotent haematopoi-
etic precursors develop into immature NK cells, which ex-
press NK-cell-specific markers partially, including similar 
levels of NKp46, NKG2D, CD11b and CD16, and express 
perforin and granzyme B both in mice and humans [28,29]. 
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With the further differentiation of immature NK cells, 
MHC-class-I-binding receptors, also known as the inhibitory 
receptors, are expressed in a multiplex and omnipresent 
manner. This process is also referred to as “NK-cell educa-
tion” [28,30]. So far the MHC class I-specific inhibitory 
receptors include the killer cell immunoglobulin-like recep-
tors (KIRs) in humans, the lectin-like Ly49 dimers in mouse, 
and the lectin-like CD94-NKG2A heterodimers in both spe-
cies [30,31]. The education process generates NK cells that 
are tolerant to self and obtain the capacity to response to 
stimulation with regard to their activating receptors. So the 
recognition and lysis of MHC-class-Ilow or MHC-class-I 
defection target cells by NK cells is aptly referred to as 
“missing-self” recognition [32,33]. Self MHC recognition 
can activate an immunoreceptor tyrosine-based inhibitory 
motif (ITIM)-dependent phosphatase SHP-1 or -2 and thus 
initiates an inhibitory signaling cascade [34]. The suitable 
expression of MHC class I molecules in normal cells and 
engagement of inhibitory receptors can avoid the autoim-
mune activity of NK cells. 
2.2  Induced-self recognition by NK cells 
NK cells can be incompetent or in-activated via the recogni-
tion of inhibitory receptor while encountering “healthy-self” 
cells. On the other hand, NK cells are regarded as the major 
force to oppose the virus infection and tumor development. 
So the integration of activation signal from the stimulatory 
receptors should conquer the inhibition of NK cells to exert 
their lytic and cytokine producing function. Transformation 
or infection might induce expression of stimulatory ligands 
so that constitutive inhibition delivered by inhibitory recep-
tors is overcome. The magnification of activation response 
due to the up-regulation of stimulatory ligands is known as 
“induced-self” recognition [35]. 
NKG2D is an important activating receptor of NK cells, 
and is the main force to initiate “induced-self” recognition 
by NK cells. NKG2D is expressed on all NK cells and a set 
of  T cells and NKT cells in mouse, as well as on all acti-
vating CD8+ T cells and intraepithelial  T cells in human 
[36]. NKG2D identifies MHC class I chain-related A chain 
(MICA) or B chain (MICB) in humans [37] and a diverse 
family of ligands shared by human and mice called the ret-
inoic acid early transcripts (RAET1) family, which includes 
RAE-1, H-60 and murine UL16-binding protein-like tran-
script 1 (MULT1) in mice and the UL16-binding protein 
(ULBP) in humans [38,39]. Interestingly, MICA and MICB 
are nearly not expressed on normal cells or tissues but can 
be induced in many epithelial tumor cells, bacterial or viral 
infected cells and in “stressed” cells [40]. Similarly, Rae-1 
and H-60 are also barely located in tumor cells of diverse 
origin but not expressed on “non-stressed” cells. So NKG2D 
recognizes endogenic ligands that are upregulated on the 
surface of most tumor or infected cells. And all the ligands 
are “induced-self” relatives of MHC class I molecules and 
adopt a MHC class I-like structure. The activation of NK 
cells mediated by “induced-self” recognition is usually 
transmitted through ITAM-containing adaptor proteins, as 
known as KARAP/DAP12 [41]. But in CD8+T cells, NKG2D 
associates solely with the signaling molecule DAP10. Col-
lectively, the crosslink of NKG2D and the self ligands 
which are induced in stress triggers responsive mechanisms 
including the production of cytokines and the enhancing 
natural cytotoxicity, which are vital for the elimination of 
infected or transformed cells. 
3  TLR signaling on NK cell activation 
It is well-known that NK cells act as first line in defense 
against tumor, viral and microbial infections. During micro-
bial infections, NK cells can be activated to kill infected or 
transformed cells and secrete large amount of cytokines to 
prime innate and adaptive immune responses. However, for 
a long time, it is not known whether NK cells can directly 
recognize pathogens. Until recently, it has been pointed that 
NK cells can be activated directly via TLRs. In other words, 
TLRs on NK cells can induce NK cell activation via inte-
grating with their respective ligands. 
It has been reported that almost all TLRs can be differen-
tially expressed on human NK cells (Table 1). TLR2, TLR3, 
TLR5 and TLR6 have the primary expression but relatively 
low expression of TLR4, TLR7, TLR8 or TLR9 on human 
NK cells [42]. The expression profile might differ in different  
Table 1  Expression of TLRs in NK and their exogenous and endogenous ligands 
TLR Expression Exogenous ligands Endogenous ligands Adaptor 
TLR2 High Peptidoglycans, glycolipids Hsp60, HMGB1 TIRAP/MyD88 
TLR3 High dsRNA, polyI:C, siRNA dsRNA MDA5, TICAM-1 
TLR5 High Flagellin Gp96, fibrinogen, -defensin2 MyD88 
TLR6 High Di-acetylated lipopeptides  TIRAP/MyD88 
TLR4 Low LPS, lipid A  TIRAP/MyD88 
TLR7 Low ssRNA40 ssRNA MyD88 
TLR8 Low ssRNA40   ssRNA MyD88 
TLR9 Low CpG-DNA DNA-containing immunocomplex MyD88 
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NK-cell populations. For example, CD56bright NK cells were 
found to preferentially express TLR2, while CD56dim NK 
cells were found to preferentially express TLR3 [43]. 
Stimulation with various TLR3 ligands can directly pro-
mote NK function, leading to the secretion of cytokines, the 
enhancement of cell lysis against virally infected or tumor 
cells. Total NK cells and CD56dim subset have been sorted 
from donors and were stimulated by poly I:C, an agonist of 
TLR3. As expected, poly I:C directly induced the secretion 
of IFN-, as well as pro-inflammatory cytokine IL-6 and 
IL-8 by NK cells in a dose-dependent manner without the 
help of other cytokines [44]. And NK cells showed a 
up-regulation of CD69 expression and enhanced cytotoxi-
city targeting K562 tumor cells [44,45]. Similarly, poly I:C 
also directly activated human NK cell lines, NK92, YTCl2 
and YTS, which all had a notable TLR3 expression [43]. 
Poly I:C stimulation up-regulated the cytotoxic activity of 
NK cells targeting K562 and 721.221 cell lines, promoted 
the secretion of IFN- and induced the CXCL10 mRNA 
without additional cytokines or cell assist [44,45]. Further 
study proved that the TLR3 stimulation can directly induce 
the activation of TRIF/TICAM-1-dependent transcription 
factor IRF-3 and p38 MAPK in these human NK cell lines, 
and activation of p38 MAPK was essential for the activation 
of NK cells [43]. The activation of NK cells mediated by 
poly I:C has been applied to the research of tumor treatment 
or anti-virus responses, looking forward to finding an effec-
tive method for tumor or infection control in clinic. In head 
and neck squamous cell carcinoma (HNSCC) patients, the 
HNSCC microenvironment made TLR3 on surface of NK 
cells internalized rapidly, but afresh stimulation of NK cells 
with poly I:C can impair the TLR3 internalization and lead 
to the activation of local NK cells, as shown as high levels 
of IFN- secretion and up-regulation of cytotoxicity target-
ing the tumor cells [46]. Similarly, TLR3 expressed on NK 
cells also plays a major role on other circumstances such as 
virus infection, especially for MCMV infection. Moreover, 
similar activation effect of NK cells stimulated by TLR9 
and possibly TLR7 and TLR8 signaling also occurs during 
MCMV infection [47]. 
There are two disparate situations on the expression of 
TLR7/8 on NK cells. TLR7/8 proteins are relative low ex-
pressed in CD56dim and CD56bright NK cells from normal 
healthy donors but are distinctly expressed in NK cell lines 
[48]. TLR7 is solely located in the NKL cell line, while 
TLR8 is highly expressed in all NK cell lines (NKL, NK92, 
and YT) [49]. Nevertheless, accumulating data show that 
TLR7/8 stimulation promotes NK cell activation and exerts 
powerful anti-tumor and anti-viral responses. NK cell acti-
vation through TLR7/8 agonists mainly requires the help of 
other cytokines, such as IL-12, IL-18, and IFN-/, which 
are secreted by DCs or monocytes [49,50]. ssRNA40 which 
contains a uridine-rich ssRNA sequence derived from the 
LTR region of HIV-1 can serve as a TLR7/8 ligand and 
activate DCs and even NK cells. The critical role of ssRNA40  
on NK cell activation has been shown in patients with acute 
viremic HIV-1 infection, in which the CD14+ monocytes 
help the activation of NK cells by secretion of IFN- and 
IL-12, and also with a cell-to-cell contact involvement [51]. 
During the past years, with the elicitation of ssRNA40, sev-
eral other single-stranded immunostimulatory RNAs (ss- 
isRNAs), which are characterized as uridine-rich oligonu-
cleotide, have been identified to be able to stimulate NK 
cells via TLR7 recognition [52]. And more important is that 
unlike other TLR7/8 agonists, these ssRNAs can mediate 
the activation of NK cells directly, represented as up-regu-      
lation of cytotoxicity against HNSCC cell lines BHY, PCI-1 
and PCI-13, induction production of IFN-, granzyme B and 
perforin by NK cells [53]. VTX-2337, a novel small-molec-     
ular TLR8 agonist, is recently found to be able to activate 
NK cells directly and augment ADCC by rituximab in 
PBMCs [54]. Stimulation with imiquimod, also known as a 
TLR7 ligand, enhances the cytotoxic activity of expanded 
NK and  T cells from cancer patients in vitro [55]. Our 
recent results showed that Imiquimod and another TLR7 
agonist, Gardiquimod, promoted the proliferation and acti-
vation of splenic T, NK and NKT cells, and increased the 
cytolytic ability of NK cells against melanoma B16. When 
combined with DC vaccine, both Imiquimod and Gardiquimod 
exert more powerful inhibition of the growth of subcutane-
ous B16 melanoma and suppression of the pulmonary me-
tastasis, demonstrating that TLR7-stimulated anti-tumor  
effect by NK cells needs the help of DCs [56]. Taken to-
gether, the activation of NK cells mediated by TLR7/8 ago-
nists should be accompanied by the stimulation of other 
cytokines. 
TLR9 regarded as another “nucleic acid-sensing” TLR al-
so has a functional expression in NK cells. The classical 
ligand of TLR9 is oligodeoxynucleotides (ODN) containing 
unmethylated CpG dinucleotides (CpG ODNs) which is 
mimics of bacterial DNA. So far three CpG ODN classes, 
also known as ODN A, ODN B and ODN C, have been 
identified and proved to bear differential capability to stim-
ulate human NK cells [57]. First of all, stimulation of 
freshly isolated NK cells with ODN C shows similar or 
higher levels of CD69 and CD25 expression as compared 
with ODN A, whereas treatment with ODN B is consistently 
less efficient [57,58]. However, in line with the TLR7/8, 
TLR9 ligands induce NK activation in virtue of suboptimal 
doses of pro-inflammatory cytokines, such as IL-12 or 
IL-18, due to low expression of TLR9 in human NK cells 
[59]. In addition, ODN C administration can up-regulate 
both cytolytic activity against tumor cell lines and cytokine 
production more significantly than ODN A and ODN B [60]. 
These results suggest that ODN C might represent a good 
volunteer to support anti-tumor therapy.  
CpG ODN has gained much attention to the tumor treat-
ment in mice model, because CpG ODN has been proved to 
be able to activate monocytes directly to secrete the Th1- 
like cytokine IL-12 and type I IFNs, promote NK cells re-
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sponse with increased lytic activity and IFN- secretion, and 
even drive dendritic cell and B cell maturation and thus en-
hance their Ag presentation capability [61]. However, the 
spontaneous antitumor immunity primed by CpG ODN can 
be tampered when ODN is applied systemically in vivo, 
therefore developing some vector-based agents for selective 
delivery of CpG-ODN is important for the activation main-
taining. In RIP1-Tag5-transgenic mouse model of pancreatic 
islet tumorigenesis, developing insulinomas are deeply em-
bedded in the exocrine pancreas and thus out of reach for 
intra-tumoral injection. CpG-ODN has been packaged into 
the vascular targeting peptide (RGR peptide) which specifically 
gets to the tumor blood vessels. RGR peptide-coated stealth 
liposomes showed a long time stimulation of spontaneous 
antitumor immunity and anti-vascular effects. RGR-lipo-     
somes plus CpG-treated RIP1-Tag5 mice display long-term 
survival, and CD8+T and NK cells are major force for this 
effect, because CD8+T and NK cells but not the CD4+T 
cells depletion impaired the survival [62]. And more im-
portant is that sorted NK cells from tumor sites exhibit more 
vigorous ability of producing IL-12 and IFN- and natural 
cytotoxicity, even accompanied by distinct inhibition of 
angiogenesis target tumor cells [62,63]. 
In addition to controlling tumor growth, TLR9-dependent 
signaling in plasmacytoid dendritic cells (pDCs) is a key 
contributor to innate immune defense against virus or bacte-
ria infection. For instance, TLR2 and TLR9 have been 
proved to act in concert to mount the first line of defense 
against HSV infection, in which the production of various 
proinflammatory cytokines, such as type I IFNs, IL-6, IL-12, 
RANTES, and TNF-, plays the major role [64]. On the 
other hand, although expression of the early activation 
marker CD69 was comparable between splenic NK1.1+ 
cells from WT and TLR2/9 DKO, reduced NK cell recruit-
ment to the spleen has been observed, resulting in more 
virus load [64]. Further study suggested that the secretion of 
chemokines such as CXCL9 and CXCL3 induced by TLR2 
or TLR9 stimulation is important for the NK activation 
[64,65]. This is also the case for MCMV infection. Overall, 
during the virus infection, TLR2/9 stimulation can mediate 
NK recruitment directly via the production of chemokines, 
as well as enhance the CD69 expression and cytokine secre-
tion. Just during the cutaneous leishmaniasis challenge, NK 
cells represent an important source for early IFN-, and 
TLR9 is essential for the induction of NK cell-related IFN- 
secretion and cytotoxicity during the innate phase of 
Leishmania (L.) major infection, because lymph node (LN) 
NK cells from TLR9–/– mice acquired no cytolytic activity 
after stimulation with L. major [66]. Further study showed 
that activation of DCs via TLR9 was essential for the induc-
tion of hypertrophy in leishmaniasis, due to the crosstalk 
between NK cells and DCs [67]. 
Besides the TLRs mentioned above, TLR2 and TLR5 
expressing on NK cells at a middle degree also can stimu-
late NK cells directly via combining with their ligands. NK 
activation mediated by TLR2 and TLR5 mainly participates 
in the defense of bacteria and fungi challenge. Klebsiella 
pneumoniae (KpOmpA) and flagellin, which represent the 
ligand of TLR2 and TLR5 respectively, can activate 
CD56+CD3NK cells directly, demonstrated as induction of 
IFN- production or increment of proinflammatory cyto-
kines such as TNF- in the presence of IL-2 [68]. More 
importantly, KpOmpA and flagellin rapidly promote NK 
cells to constitutively produce -defensins which disrupted 
the bacterial membrane, leading to pathogen death [68]. 
Similarly, TLR2 is involved to assist NK cells to recognize 
H. pylori to promote the production of IFN- which is the 
major inflammation factor in the human gastric mucosa [69]. 
In vaccinia viral infection, TLR2 was able to directly acti-
vate NK cell in a TLR2/MyD88-dependent manner and was 
critical for the control of vaccinia viral infection in vivo [70]. 
TLR2 agonist polysaccharide krestin (PSK) was also re-
ported to activate human NK cells directly and indirectly 
with the help of IL-12. Notably, it can enhance the anti-
tumor effect of HER2-targeted monoclonal antibody thera-
py [71]. In addition, a bacterial fimbrial protein FimH, a 
novel TLR4 ligand, was recently reported to directly acti-
vate human and murine natural killer cells via TLR4- 
MyD88 pathways [72]. 
Ligation of TLRs with respective agonists at the site of 
infection or cellular stress activates NK cells followed by 
the release of inflammatory mediators, including cytokines 
and chemokines, and initiation of target-cell lysis. However, 
the activation of NK cells mediated by TLRs is also in-
volved in some pathologic process of autologous diseases. 
For example, poly I:C treatment can induce the accumula-
tion and activation of NK cells in liver, leading to autoim-
mune hepatitis [73,74]. Pre-activation of T cells aggravates 
poly I:C-induced liver injury by up-regulating NK cell 
function [75]. HBs-transgenic mice are over-sensitive to 
poly I:C-induced liver injury, which is dependent on the 
presence of NK cells and IFN- produced by intrahepatic 
NK cells [76,77]. In primary biliary cirrhosis (PBC), stimu-
lation with ligands for TLR3 and TLR4 enhanced NK cell- 
mediated cytotoxicity against biliary epithelial cells (BECs), 
during which IFN- produced by TLR3 ligand-stimulated 
monocytes enhances the cytotoxicity of TLR4 ligand-acti-     
vated NK cells [78]. In addition, the stimulation of TLR3 
can also trigger murine uterus NK cell activation followed 
by amounts of TNF- and IFN- secretion. These two fac-
tors can induce the reconstruction of artery and promote the 
abortion [79]. 
4  The crosstalk between TLR and NK cell  
receptors 
Accumulating evidence has shown that NK cells can recog-
nize pathogen-associated structures directly or indirectly. 
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However, it is not clear how TLR signaling results in NK 
cell activation. Increasing data has indicated that there exists 
crosstalk between TLR and NK cell receptors, and therefore 
regulates NK cell function. 
KIRs are human NK receptors that recognize allotypic 
determinants of human leukocyte antigen (HLA) class I. 
The major function of inhibitory KIRs is discriminating 
normal cells from tumor or virus-infected cells via recog-
nizing the HLA class I molecules (HLA-A, -B or -C allo-
types). As one of the members of KIRs, KIR3DL2 has been 
reported to be capable of binding CpG-ODNs (such as 
ODN-C) and transiting themselves into the endosomal 
compartments of NK cells and therefore down-modulating 
surface KIR3DL2 expression [80]. The disappearance of 
KIR3DL2 mediated by TLR9 stimulation is beneficial for 
the activation of NK cells to counteract the pathogen chal-
lenge. The stimulation of CpG-ODNs did not impair the 
expression of other surface receptors, including NKG2D, 
NKG2A, CD16, CD56, DNAM-1, CD2, LFA-1, 2B4 and 
NTBA [81,82].  
The expression of activating receptors and their ligands 
is also regulated by TLR pathway to influence NK cell 
function when suffering the microbe infection or cell stress. 
The NKG2D receptor which is the primary activating re-
ceptor can be upregulated when “stressed-induced” signals 
emerge. Accumulating data demonstrates that TLR signal-
ing might tempt the NKG2D expression on NK cells or oth-
er NKG2D-expressing lymphocytes, and/or simultaneously 
induce expression of NKG2D ligands on NK-targeting cells 
to strengthen NK activation. For instance, during the infec-
tion of intracellular Mycobacterium tuberculosis (M. tb), 
lysis of infected mononuclear phagocytes mediated by NK 
cells is the main force to clear away microbial pathogens, in 
which natural cytotoxicity receptors on NK cells such as 
NKp30, NKp44 and NKp46 play a pivotal role [83,84]. The 
expression of NKp46, NKp30 and NKG2D has been identi-
fied to be markedly increased on NK cells upon exposure to 
M. tb-infected cells, and NKG2D and NKp46 are vital for 
NK cell lysis of M.tb-infected monocytes, which was con-
firmed by neutralization antibodies. More importantly, M. tb 
infection can up-regulate ULBP1 expression on monocytes 
through stimulating TLR2 signaling [84]. This induction of 
both receptor and ligand can enhance cytotoxicity of NK 
cells. So these results indicate that interactions between the 
TLR2 pathway and NK cells can contribute to the local 
immune response to M. tb infection. 
Large amount of data has shown that TLR signaling en-
hances NK cell activation through strengthening the interac-
tions between NKG2D and its ligands via up-regulating 
NKG2D ligands on macrophages, monocytes or tumor cells. 
Previously reports showed that LPS preferentially upregu-
lated MICA but not MICB, while CL097 stimulation re-
sulted in upregulation of both MICA and MICB. Multiple 
mechanisms downstream of TLR4 stimulation, such as 
ATM/ATR kinases and miRNAs, regulate expression of 
NKG2D ligands, which were involved in the macrophage/ 
NK cell crosstalk [85]. Our recent published data showed 
that poly I:C-stimulated murine macrophages can enhance 
NK cell-mediated anti-tumor effects, which is dependent on 
the interaction of NKG2D and its ligands RAE-1, H60, and 
MULT-1 [86]. Similar effects also occur in crosstalk be-
tween NK and monocytes. The up-regulation of MICA ex-
pression and human monocytes activation upon LPS stimu-
lation in turn enhances the NK cells activity manifested by 
the induction of IFN- secretion via NKG2D-ligands inter-
action and augments NK cytolysis against tumor cells. More 
important was that activated NK cells did not display cyto-
toxicity against MICA-expressing monocytes to avoid au-
tologous immune disorder [87].  
In addition to inducing the activation of NK cells via up- 
regulating the NKG2D ligands on macrophages or mono-
cytes to complete the mission of resisting microbe infection 
or tumor challenge, TLR signaling-induced NK cell activa-
tion may also mediate autologous disorder via affecting the 
reciprocity of NKG2D-ligands. In a polyI:C/D-GalN-induced 
fulminant hepatitis, in which TLR3 stimulation with polyI: 
C triggered the up-regulation expression of Rae-1 on the 
surface of Kupffer cells, the crosstalk between NK cells and 
Kupffer cells via NKG2D-Rae1 recognition resulted in 
IFN- and TNF- secretion which were major factors in-
volved in liver injury [88]. Poly I:C was also reported to 
activate hepatic NK cells and ameliorate liver fibrosis 
through enhancing NKG2D expression on NK cells and 
Rae-1 expression on hepatic stellate cells and then killing 
stellate cells in NKG2D- and TRAIL-dependent manner 
[89].  
Besides mediating the liver injury via intensifying the 
interaction of NKG2D and respective ligand, TLR stimula-
tion can induce other immune disorders through promoting 
NK activation. In human skeletal muscle cell lines such as 
myoblasts and human rhabdomyosarcoma cells (TE671), 
there are low mRNA expression of TLR1-7 and TLR9 but 
constitutively expression of TLR3 which can be up-regu-     
lated by poly(I:C) [90]. Moreover, TLR3 engagement with 
poly(I:C) or other dsRNA is capable of initiating the in-
crease of NKG2D on NK cells, and also the up-regulation 
of respective ligands such as MICA, MICB, ULBP-2 and 
ULBP-3 in human muscle cells [91]. The interaction be-
tween NKG2D and ligands results in autologous cytotoxi-
city and the secretion of IL-8 and tissue inhibitor of metal-
loproteinase-2 (TIMP-2), which can aggravate the devel-
opment of sarcolysis [90]. The activation of TLR signaling 
also breaks down epithelial homeostasis of small intestine in 
mice. Poly I:C stimulation could urge intestinal epithelial 
cells (IECs) to express RAE-1 and promote NKG2D ex-
pression on CD8+ intestinal intraepithelial lymphocytes in 
the presence of IL-15 derived from TLR3-activated IECs. 
The blockade of interaction between NKG2D and RAE-1 
inhibited the cytotoxicity of intraepithelial lymphocytes 
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against IECs consequently to alleviate epithelial destruction 
and acute mucosal injury of small intestine mediated by 
poly I:C [92]. This is also the case for the full development 
of renal ischemia-reperfusion injury (IRI). Published results 
have proved that ischemic injury resulted in the generation 
or release of various endogenous ligands of TLRs, including 
HMGB1, biglycan, and heat shock proteins. The coalescent 
of TLR4 and its ligand HMGB1 has been found to be in-
volved in the progress of IRI [93]. Recent finding showed 
that in ischemic kidney of BABL/c mouse, RAE-1 and 
MULT-1 expression on renal tubular epithelial cells and 
NKG2D expression on renal NK cells both could be up- 
regulated and TLR2/MyD88 signaling was responsible for 
the increase of NKG2D and respective ligands directly be-
cause further induction was restricted in both TLR2/ and 
MyD88/ mice [94].  
Collectively, the crosstalk between TLR and NK cell re-
ceptors not only plays major roles in control of NK cell 
function and participates in the defense of NK cells against 
infection and transformation, but also participates in patho-
genesis of some diseases. 
5  TLRs—The hinge connecting DCs and NK cells 
Customarily, DCs are known as the professional antigen 
presentation cells which present antigens to acquired im-
mune cells such as T and B lymphocytes, followed by the 
robust activation of entire immune system. But more and 
more data have shown that DCs also play a very important 
role in control of the innate immune responses. It is un-
doubted that DCs can trigger NK cells directly via the se-
cretion of cytokines, such as IL-12 and IL-15, which pro-
mote NK-cell survival and differentiation, NK cell-medi-     
ated cytotoxicity and IFN- secretion [95]. Herein we 
demonstrate that TLRs highly expressed on DCs act as a 
bridge between DCs and NK cells, that is, TLR ligands can 
stimulate DCs, and consequently activate NK cells through 
cytokine secretion and/or cell-to-cell contact. 
pDCs are bone marrow-derived leukocytes that secrete 
large amounts of type I IFN in response to a variety of vi-
ruses. And two endosomal sensors, TLR7 and TLR9 both 
have a remarkable expression in pDCs. Moreover, pDCs are 
responsible for the early peak of IFN production in response 
to most viruses or TLR7 and TLR9 agonists [96]. In line 
with previous reports, the activation of NK cells mediated 
by TLR9 recognition depends on the presence of cytokines 
probably from other immune cells, but the exact role of 
pDCs played in the activation of NK cells induced by TLR 
has not been validated. It has been proved that TLR9-engage-     
ment with CpG-A in human pDCs induces NK cell activa-
tion, represented as the up-regulation of CD69 expression, 
as well as proliferation of CD56brightCD16 NK cells. 
Moreover, extensive research showed that the activation and 
proliferation of NK cells promoted by pDCs after TLR9 
stimulation could be augmented by the addition of CD4+ 
CD25 Th cells in a IL-2-dependent manner, but was com-
pletely abrogated by the CD4+CD25hi Treg cells [97]. It has 
been demonstrated that during MCMV infection, the pro-
duction of type I IFN by pDCs is vital for NK cell activation 
and function. Recent findings show that during persistent 
MCMV infection, IFN- production and cytotoxic capacity 
of NK cells is inhibited dramatically due to the defect of 
type I IFN response from pDCs [98]. When wild-type (WT) 
BALB/c mice encounter the challenge of some Gram-nega-    
tive bacteria, such as Klebsiella pneumoniae, pDCs ex-
pressing TLR9 accumulate rapidly, followed by the increase 
of total number of DX5+cell. If CpG-stimulated CD11cdulll 
B220+ pDCs are injected into the infected mice, the re-
cruitment of NK cells to the peritoneum can be induced 
drastically followed by the high expression of CXCR3 and 
CD62L, and moderate expression of CCR5 [99]. And these 
NK cells isolated from the peritoneum inoculated with 
TLR7/8 or TLR9-stimulated pDCs exhibit highlighted cy-
totoxicity against YAC-1 tumor cells. These findings sug-
gest that although the TLRs stimulation on the NK cells can 
directly enhance their ability to produce cytokines and lyse 
infected or transformed cells, the response of DCs to TLR 
agonists is pivotal for the recruitment and proliferation of 
NK cells. About the recruitment of NK cells mediated by 
DCs, there are many related details. By using a mouse mod-
el for the ablation of DCs, the priming of NK cell responses 
to viral and bacterial pathogens was proved to require the 
help of CD11chigh DCs [98]. After peripheral TLR stimula-
tion, NK cells were recruited to local lymph nodes, and their 
interaction with DCs resulted in the emergence of effector 
NK cells in the periphery. NK cell priming was dependent 
on the recognition of type I IFN signals by DCs and the 
subsequent production and trans-presentation of IL-15 by 
DCs to resting NK cells. CD11chigh DC-derived IL-15 was 
vital and sufficient for the priming of NK cells. 
Conventional DCs (cDCs) in fact are veiled cells of my-
eloid origin which are capable of efficiently processing and 
presenting antigens to prime naive T cells [100]. Although 
pDCs are characterized as the type I IFN-production in re-
sponse to virus or bacterium components, they cannot ex-
crete IFN- by poly I:C stimulation. In contrast, CD11c+-    
B220 cDCs produce type I IFNs in response to poly I:C. 
Moreover, CD8+ cDCs in response to poly I:C stimulation 
can enhance cytotoxicity of NK cells targeting YAC-1 tu-
mor cells, and up-regulate the expression of granzyme B 
and IFN- due to the activation of IPS-1 and TRIF signaling 
pathway and consequently up-regulate the expression of 
type I IFNs, IL-6, and IL-12p40 in DCs [101]. Similar to 
pDCs, cDCs also promote the recruitment of NK cells after 
TLRs-related ligands stimulation via up-regulating the se-
cretion of chemokines. Some investigators showed that in 
mice with depletion of CD11c+ MHC class II+ cDCs, the 
recruitment of CXCR5+DX5+ NK cells to draining lymph  
nodes is abated after treatment with TLR4 and TLR5 ago-
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nists, although these TLR ligands also can activate NK cells 
in the draining lymph nodes [102]. DCs are now accepted as 
crucial regulators of innate and adaptive immunity, in par-
ticular NK cells function. It is undoubtful that the IFN- 
secretion, cytotoxicity, CD69 expression and proliferation 
of resting NK cells can be induced by mouse DC cell lines, 
mouse bone-marrow-derived DCs (BMDCs), human mon-
ocyte-derived DCs and human cord-blood-derived DCs 
[103]. So far the mechanisms involved in which DCs acti-
vate NK cells include the direct cell-cell contact and soluble 
factors, including IL-12, IL-18 and type I IFN. Moreover, 
some researchers have begun to reveal intrinsic relations 
between NK cells and DCs when stimulated by diversified 
TLR agonists or other stimulus. Myeloid DCs (mDCs), 
which comprise many subsets, including BMDCs and CD8+ 
DCs, possess subset-specific pattern-recognition systems. 
After stimulation with TLR agonists, adaptor MyD88 or the 
Toll/IL-1 receptor homology domain-containing adaptor 
molecule (TICAM)-1 (TRIF) is recruited and transduces 
signaling to engaged in type I IFN induction and NK activa-
tion via partly overlapped but distinct pathways in a cell 
type-specific manner [104]. MyD88 in pDC can be stimu-
lated after administration of TLR7 or TLR9 ligand to pro-
mote IFN- secretion, and consequently, NK cells demon-
strate further activation [95,96]. This is also the case for 
TLR2 agonist, because cell contact-mediated NK activation  
is hampered when the cells are stimulated with Pam2 
lipopeptide after coincubation with MyD88/ mDC [70]. In 
contrast, poly I:C-induced NK activation is tampered in 
double KO (IPS-1/ and TICAM-1/) mice, suggesting that 
these two pathways are both required for poly I:C-mediated 
NK activation [105]. Moreover, regulatory molecule which 
is responsible for the crosstalk between NK and mDC has 
been reported. INAM (IRF-3-dependent NK cell activating 
molecule), a poly I:C-inducible membrane protein, has 
been identified to participate in mDC-mediated NK cell 
activation and contribute to mDC-NK reciprocal activation 
[104,106]. Notably, INAM does not act as an NK-activating 
ligand; it works only on mDC/macrophage for NK activa-
tion. In addition, MyD88 in NK cells also participates in 
direct NK activation. 
6  Future prospect 
TLRs and NK cell receptors are the most important receptor 
superfamilies in innate immunity. TLRs, acting as the sen-
sor of external pathogens, lie in the first defense line to re-
sist the invasion from xenogenic organisms by directly rec-
ognizing PMAPs. NK cells can eliminate pathogenic infec-
tion or transformed-cells via detecting alterations in endog-
enous protein expression on target cells through activating  
 
Figure 1  The TLR signaling in NK cell activation. 
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and inhibitory receptors. Accumulating data has demon-
strated that TLRs and NK cell receptors can coordinate and 
regulate each other during immune responses, which con-
tributes to the initiation of innate response and the priming 
of adaptive responses. TLRs can activate NK cell function 
directly or with the help of accessory cells in a cytokine or 
cell-to-cell contact dependent manner. In addition, TLR 
signaling can also induce the expression of NKG2D ligand 
and thus indirectly activate NK cells. As shown in Figure 1, 
NK cells express diversified TLRs, and they can be activated 
directly by TLR ligands, followed by the activation of TLR 
signaling pathway via the recruitment of TIR domain-con-     
taining adaptor molecules, including MyD88, TIRAP (Mal), 
TRIF and TRAM. In most cases, TLR-induced NK cell ac-
tivation needs the help of accessory cells, such as DCs, 
macrophages and monocytes. For example, TLR agonists 
stimulate TLRs on the surface or in the endosome of DCs 
and finally promote the production of inflammatory cyto-
kines such as IL-12, IL-15, and type I IFN, which are vital 
for NK activation. Moreover, cell-to-cell contact between 
DC and NK cells is crucial for NK cell activation. DC acti-
vation can induce the expression of INAM to enhance the 
function of NK, although the exact role of INAM players in 
the mDC-NK contact is still unidentified. Taken together, 
TLR signaling can directly or indirectly induce the activa-
tion of NK cells, thereby promoting IFN- secretion and 
enhancing cytotoxicity against tumor or infected cells. 
In conclusion, the TLR signaling is critical for NK cell 
activation and function in the control of viral or bacterial 
infection and cancer. Other innate immune receptors, such 
as RLRs, NLRs, and CLRs, may also interact with NK cell 
receptors or intracellular signaling, and contribute to NK 
cell activity. Although the progress has been gained in re-
cent years, the precise crosstalk between different immune 
cells and different receptors should be investigated more 
intensively. More understanding of the recognition of innate 
receptors and interactions between them may provide im-
portant insights into the design of effective strategies to 
combat tumor and microbial infections.  
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